Ampio Pharmaceuticals is having an incredibly strong day in the market today. When the opening bell rang, the stock quickly found itself well into the green. Through the the trading session, the stock has continued …
Soaring
We believe AMPE is trying to raise money through a secondary. Management previously ran an alleged stock promotion. AMPE's development assets are worthless. We had a number of conference calls with the …
Secondary
Ampio Pharmaceutical (AMPE): AMPE stock is up 17.78% today ... Article printed from InvestorPlace Media, http://investorplace.com/2016/04/biggest-movers-in-manufacturing-stocks-now-aktx-crmd-ampe-regn/.
However, that could all change as better prices and stock valuations make a more tempting realisation ... and there is no doubt that the re …
Nikon FG
How have hedgies been trading Ampio Pharmaceuticals, Inc. (NYSEMKT:AMPE)? Heading into Q4, a total of 5 of the hedge funds tracked by Insider Monkey were long this stock, a change of -44% from the previous quarter. …
Ampio Pharmaceuticals, Inc. ( AMPE) was a big mover last session, as the company saw its shares rise over 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal …
traders have been relatively bearish on Ampio Pharmaceuticals (AMPE), hence the stock is down -69.35% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is …
We believe Ampio Pharmaceuticals (NYSEMKT:AMPE) is a stock promotion that is run by management with an alleged history of fraud and is aggressively promoting itself in preparation for a secondary. AMPE is quickly …